Skip to main content
Erschienen in: Cancer Immunology, Immunotherapy 11/2009

01.11.2009 | Original article

Dynamic changes of interleukin-8 network along the colorectal adenoma–carcinoma sequence

verfasst von: Guanglin Cui, Aping Yuan, Rasmus Goll, Barthold Vonen, Jon Florholmen

Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 11/2009

Einloggen, um Zugang zu erhalten

Abstract

The interleukin-8 (IL-8) network is involved in the colorectal cancer (CRC) progression. However, its role during the adenoma–carcinoma transition to date has not been fully investigated. To evaluate the dynamic changes of IL-8 network along the colorectal adenoma–carcinoma sequence, we examined the tissue IL-8 mRNA level in colorectal biopsies from 53 colorectal adenomas, 44 CRCs and 18 controls by quantitative real-time PCR (Q-PCR), and the expressions of IL-8 and its receptors (IL-8RA and IL-8RB) in the tumor microenvironment by immunohistochemistry (IHC) and double IHCs. The results showed that the tissue IL-8 mRNA level began to increase in the precancerous lesions (adenomas) as compared with the controls and became even higher in the CRCs. Significantly, the increase of IL-8 mRNA levels was associated with the increase of dysplastic grades in the adenomas, and also paralleled to the increase of Duke’s stages in the CRCs. IHC results revealed that IL-8 and its receptors, IL-8RA and IL-8RB, were observed both in the stroma and in the adenomatous/cancerous cells. By double IHCs, the IL-8 expression was characterized in macrophages, lymphocytes and myofibroblasts in the tumor stroma. Further double IHC identified the co-expression of IL-8 receptors (IL-8RA and IL-8RB) with CD34 positive tumor-associated microvessels in both the adenomas and CRCs. We, therefore, conclude that activated IL-8 network in the tumor microenvironment may function as a significant regulatory factor for the adenoma progression and the adenoma–carcinoma transition.
Literatur
2.
Zurück zum Zitat Leslie A, Carey FA, Pratt NR, Steele RJ (2002) The colorectal adenoma–carcinoma sequence. Br J Surg 89:845–860PubMedCrossRef Leslie A, Carey FA, Pratt NR, Steele RJ (2002) The colorectal adenoma–carcinoma sequence. Br J Surg 89:845–860PubMedCrossRef
3.
Zurück zum Zitat Young J, Jass JR (2006) The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Cancer Epidemiol Biomark Prev 15:1778–1784CrossRef Young J, Jass JR (2006) The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Cancer Epidemiol Biomark Prev 15:1778–1784CrossRef
4.
Zurück zum Zitat Habermann JK, Paulsen U, Roblick UJ, Upender MB, McShane LM, Korn EL, Wangsa D, Kruger S, Duchrow M, Bruch HP, Auer G, Ried T (2007) Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis. Genes Chromosomes Cancer 46:10–26PubMedCrossRef Habermann JK, Paulsen U, Roblick UJ, Upender MB, McShane LM, Korn EL, Wangsa D, Kruger S, Duchrow M, Bruch HP, Auer G, Ried T (2007) Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis. Genes Chromosomes Cancer 46:10–26PubMedCrossRef
5.
Zurück zum Zitat Mizoshita T, Tsukamoto T, Inada KI, Hirano N, Tajika M, Nakamura T, Ban H, Tatematsu M (2007) Loss of MUC2 expression correlates with progression along the adenoma–carcinoma sequence pathway as well as de novo carcinogenesis in the colon. Histol Histopathol 22:251–260PubMed Mizoshita T, Tsukamoto T, Inada KI, Hirano N, Tajika M, Nakamura T, Ban H, Tatematsu M (2007) Loss of MUC2 expression correlates with progression along the adenoma–carcinoma sequence pathway as well as de novo carcinogenesis in the colon. Histol Histopathol 22:251–260PubMed
6.
Zurück zum Zitat Staton CA, Chetwood AS, Cameron IC, Cross SS, Brown NJ, Reed MW (2007) The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer. Gut 56:1426–1432PubMedCrossRef Staton CA, Chetwood AS, Cameron IC, Cross SS, Brown NJ, Reed MW (2007) The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer. Gut 56:1426–1432PubMedCrossRef
7.
Zurück zum Zitat Lee S, Bang S, Song K, Lee I (2006) Differential expression in normal–adenoma–carcinoma sequence suggests complex molecular carcinogenesis in colon. Oncol Rep 16:747–754PubMed Lee S, Bang S, Song K, Lee I (2006) Differential expression in normal–adenoma–carcinoma sequence suggests complex molecular carcinogenesis in colon. Oncol Rep 16:747–754PubMed
8.
Zurück zum Zitat Yuan A, Chen JJ, Yao PL, Yang PC (2005) The role of interleukin-8 in cancer cells and microenvironment interaction. Front Biosci 10:853–865PubMedCrossRef Yuan A, Chen JJ, Yao PL, Yang PC (2005) The role of interleukin-8 in cancer cells and microenvironment interaction. Front Biosci 10:853–865PubMedCrossRef
9.
10.
Zurück zum Zitat Li A, Dubey S, Varney ML, Dave BJ, Singh RK (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170:3369–3376PubMed Li A, Dubey S, Varney ML, Dave BJ, Singh RK (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170:3369–3376PubMed
11.
Zurück zum Zitat Li A, Varney ML, Valasek J, Godfrey M, Dave BJ, Singh RK (2005) Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis 8:63–71PubMedCrossRef Li A, Varney ML, Valasek J, Godfrey M, Dave BJ, Singh RK (2005) Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis 8:63–71PubMedCrossRef
12.
Zurück zum Zitat Li A, Varney ML, Singh RK (2001) Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res 7:3298–3304PubMed Li A, Varney ML, Singh RK (2001) Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res 7:3298–3304PubMed
13.
Zurück zum Zitat Chung YC, Chang YF (2003) Significance of inflammatory cytokines in the progression of colorectal cancer. Hepatogastroenterology 50:1910–1913PubMed Chung YC, Chang YF (2003) Significance of inflammatory cytokines in the progression of colorectal cancer. Hepatogastroenterology 50:1910–1913PubMed
14.
Zurück zum Zitat Itoh Y, Joh T, Tanida S, Sasaki M, Kataoka H, Itoh K, Oshima T, Ogasawara N, Togawa S, Wada T, Kubota H, Mori Y, Ohara H, Nomura T, Higashiyama S, Itoh M (2005) IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells. Cytokine 29:275–282PubMed Itoh Y, Joh T, Tanida S, Sasaki M, Kataoka H, Itoh K, Oshima T, Ogasawara N, Togawa S, Wada T, Kubota H, Mori Y, Ohara H, Nomura T, Higashiyama S, Itoh M (2005) IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells. Cytokine 29:275–282PubMed
15.
Zurück zum Zitat Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE (2000) Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 12:78–85PubMedCrossRef Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE (2000) Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 12:78–85PubMedCrossRef
16.
Zurück zum Zitat Brew R, Southern SA, Flanagan BF, McDicken IW, Christmas SE (1996) Detection of interleukin-8 mRNA and protein in human colorectal carcinoma cells. Eur J Cancer A 32:2142–2147CrossRef Brew R, Southern SA, Flanagan BF, McDicken IW, Christmas SE (1996) Detection of interleukin-8 mRNA and protein in human colorectal carcinoma cells. Eur J Cancer A 32:2142–2147CrossRef
17.
Zurück zum Zitat Lurje G, Zhang W, Schultheis AM, Yang D, Groshen S, Hendifar AE, Husain H, Gordon MA, Nagashima F, Chang HM, Lenz HJ (2008) Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer. Ann Oncol 19:1734–1741PubMedCrossRef Lurje G, Zhang W, Schultheis AM, Yang D, Groshen S, Hendifar AE, Husain H, Gordon MA, Nagashima F, Chang HM, Lenz HJ (2008) Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer. Ann Oncol 19:1734–1741PubMedCrossRef
18.
Zurück zum Zitat Ueda T, Shimada E, Urakawa T (1994) Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis. J Gastroenterol 29:423–429PubMedCrossRef Ueda T, Shimada E, Urakawa T (1994) Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis. J Gastroenterol 29:423–429PubMedCrossRef
19.
Zurück zum Zitat Rubie C, Frick VO, Pfeil S, Wagner M, Kollmar O, Kopp B, Graber S, Rau BM, Schilling MK (2007) Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer. World J Gastroenterol 13:4996–5002PubMed Rubie C, Frick VO, Pfeil S, Wagner M, Kollmar O, Kopp B, Graber S, Rau BM, Schilling MK (2007) Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer. World J Gastroenterol 13:4996–5002PubMed
20.
Zurück zum Zitat Bates RC, DeLeo MJIII, Mercurio AM (2004) The epithelial-mesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR-1-mediated chemotaxis. Exp Cell Res 299:315–324PubMedCrossRef Bates RC, DeLeo MJIII, Mercurio AM (2004) The epithelial-mesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR-1-mediated chemotaxis. Exp Cell Res 299:315–324PubMedCrossRef
21.
Zurück zum Zitat Waugh DJ, Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14:6735–6741PubMedCrossRef Waugh DJ, Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14:6735–6741PubMedCrossRef
22.
Zurück zum Zitat Miller MD, Krangel MS (1992) Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 12:17–46PubMed Miller MD, Krangel MS (1992) Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 12:17–46PubMed
23.
Zurück zum Zitat Terada H, Urano T, Konno H (2005) Association of interleukin-8 and plasminogen activator system in the progression of colorectal cancer. Eur Surg Res 37:166–172PubMedCrossRef Terada H, Urano T, Konno H (2005) Association of interleukin-8 and plasminogen activator system in the progression of colorectal cancer. Eur Surg Res 37:166–172PubMedCrossRef
24.
Zurück zum Zitat Cui G, Olsen T, Christiansen I, Vonen B, Florholmen J, Rasmus G (2006) Improvement of real-time PCR for quantifying TNF-a mRNA expression in inflamed colorectal mucosa—an approach to optimize procedures for clinical use. Scand J Clin Lab Invest 66:249–259PubMedCrossRef Cui G, Olsen T, Christiansen I, Vonen B, Florholmen J, Rasmus G (2006) Improvement of real-time PCR for quantifying TNF-a mRNA expression in inflamed colorectal mucosa—an approach to optimize procedures for clinical use. Scand J Clin Lab Invest 66:249–259PubMedCrossRef
25.
Zurück zum Zitat Goll R, Gruber F, Olsen T, Cui G, Raschpichler G, Buset M, Asfeldt AM, Husebekk A, Florholmen J (2007) Helicobacter pylori stimulates a mixed adaptive immune response with a strong T-regulatory component in human gastric mucosa. Helicobacter 12:185–192PubMedCrossRef Goll R, Gruber F, Olsen T, Cui G, Raschpichler G, Buset M, Asfeldt AM, Husebekk A, Florholmen J (2007) Helicobacter pylori stimulates a mixed adaptive immune response with a strong T-regulatory component in human gastric mucosa. Helicobacter 12:185–192PubMedCrossRef
26.
Zurück zum Zitat Cui G, Yuan A, Goll R, Olsen T, Husebekk A, Vonen B, Florholmen J (2007) Distinct changes of dendritic cell number and IL-12 mRNA level in adjacent mucosa throughout the colorectal adenoma–carcinoma sequence. Cancer Immunol Immunother 56:1993–2001PubMedCrossRef Cui G, Yuan A, Goll R, Olsen T, Husebekk A, Vonen B, Florholmen J (2007) Distinct changes of dendritic cell number and IL-12 mRNA level in adjacent mucosa throughout the colorectal adenoma–carcinoma sequence. Cancer Immunol Immunother 56:1993–2001PubMedCrossRef
27.
Zurück zum Zitat Yuan A, Steigen SE, Goll R, Vonen B, Husbekk A, Cui G, Florholmen J (2008) Dendritic cell infiltration pattern along the colorectal adenoma–carcinoma sequence. Apmis 116:445–456PubMedCrossRef Yuan A, Steigen SE, Goll R, Vonen B, Husbekk A, Cui G, Florholmen J (2008) Dendritic cell infiltration pattern along the colorectal adenoma–carcinoma sequence. Apmis 116:445–456PubMedCrossRef
28.
Zurück zum Zitat Cui G, Koh TJ, Chen D, Zhao CM, Takaishi S, Dockray GJ, Varro A, Rogers AB, Fox JG, Wang TC (2004) Overexpression of glycine-extended gastrin inhibits parietal cell loss and atrophy in the mouse stomach. Cancer Res 64:8160–8166PubMedCrossRef Cui G, Koh TJ, Chen D, Zhao CM, Takaishi S, Dockray GJ, Varro A, Rogers AB, Fox JG, Wang TC (2004) Overexpression of glycine-extended gastrin inhibits parietal cell loss and atrophy in the mouse stomach. Cancer Res 64:8160–8166PubMedCrossRef
29.
Zurück zum Zitat Li Z, Liu J, Tang F, Liu Y, Waldum HL, Cui G (2008) Expression of non-mast cell histidine decarboxylase in tumor-associated microvessels in human esophageal squamous cell carcinomas. Apmis 116:1034–1042PubMedCrossRef Li Z, Liu J, Tang F, Liu Y, Waldum HL, Cui G (2008) Expression of non-mast cell histidine decarboxylase in tumor-associated microvessels in human esophageal squamous cell carcinomas. Apmis 116:1034–1042PubMedCrossRef
30.
Zurück zum Zitat Cui G, Goll R, Olsen T, Steigen SE, Husebekk A, Vonen B, Florholmen J (2007) Reduced expression of microenvironmental Th1 cytokines accompanies adenomas–carcinomas sequence of colorectum. Cancer Immunol Immunother 56:985–995PubMedCrossRef Cui G, Goll R, Olsen T, Steigen SE, Husebekk A, Vonen B, Florholmen J (2007) Reduced expression of microenvironmental Th1 cytokines accompanies adenomas–carcinomas sequence of colorectum. Cancer Immunol Immunother 56:985–995PubMedCrossRef
31.
Zurück zum Zitat Cacev T, Radosevic S, Krizanac S, Kapitanovic S (2008) Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis 29:1572–1580PubMedCrossRef Cacev T, Radosevic S, Krizanac S, Kapitanovic S (2008) Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis 29:1572–1580PubMedCrossRef
32.
Zurück zum Zitat Brew R, Erikson JS, West DC, Flanagan BF, Christmas SE (1997) Interleukin-8 as a growth factor for human colorectal carcinoma cells in vitro. Biochem Soc Trans 25:264SPubMed Brew R, Erikson JS, West DC, Flanagan BF, Christmas SE (1997) Interleukin-8 as a growth factor for human colorectal carcinoma cells in vitro. Biochem Soc Trans 25:264SPubMed
33.
Zurück zum Zitat Wigmore SJ, Maingay JP, Fearon KC, Ross JA (2001) Endogenous production of IL-8 by human colorectal cancer cells and its regulation by cytokines. Int J Oncol 18:467–473PubMed Wigmore SJ, Maingay JP, Fearon KC, Ross JA (2001) Endogenous production of IL-8 by human colorectal cancer cells and its regulation by cytokines. Int J Oncol 18:467–473PubMed
34.
Zurück zum Zitat Haraguchi M, Komuta K, Akashi A, Matsuzaki S, Furui J, Kanematsu T (2002) Elevated IL-8 levels in the drainage vein of resectable Dukes’ C colorectal cancer indicate high risk for developing hepatic metastasis. Oncol Rep 9:159–165PubMed Haraguchi M, Komuta K, Akashi A, Matsuzaki S, Furui J, Kanematsu T (2002) Elevated IL-8 levels in the drainage vein of resectable Dukes’ C colorectal cancer indicate high risk for developing hepatic metastasis. Oncol Rep 9:159–165PubMed
35.
Zurück zum Zitat Fantini MC, Pallone F (2008) Cytokines: from gut inflammation to colorectal cancer. Curr Drug Targets 9:375–380PubMedCrossRef Fantini MC, Pallone F (2008) Cytokines: from gut inflammation to colorectal cancer. Curr Drug Targets 9:375–380PubMedCrossRef
36.
Zurück zum Zitat Almholt K, Johnsen M (2003) Stromal cell involvement in cancer. Recent Results Cancer Res 162:31–42PubMed Almholt K, Johnsen M (2003) Stromal cell involvement in cancer. Recent Results Cancer Res 162:31–42PubMed
37.
Zurück zum Zitat De Wever O, Mareel M (2003) Role of tissue stroma in cancer cell invasion. J Pathol 200:429–447PubMedCrossRef De Wever O, Mareel M (2003) Role of tissue stroma in cancer cell invasion. J Pathol 200:429–447PubMedCrossRef
38.
Zurück zum Zitat Cui G, Yuan A, Vonen B, Florholmen J (2009) Progressive cellular response in the lamina propria of the colorectal adenoma–carcinoma sequence. Histopathology (in press) Cui G, Yuan A, Vonen B, Florholmen J (2009) Progressive cellular response in the lamina propria of the colorectal adenoma–carcinoma sequence. Histopathology (in press)
39.
Zurück zum Zitat Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB (2003) The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma–carcinoma sequence during colorectal cancer progression. J Pathol 200:183–194PubMedCrossRef Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB (2003) The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma–carcinoma sequence during colorectal cancer progression. J Pathol 200:183–194PubMedCrossRef
40.
Zurück zum Zitat Shpitz B, Gochberg S, Neufeld D, Grankin M, Buklan G, Klein E, Bernheim J (2003) Angiogenic switch in earliest stages of human colonic tumorigenesis. Anticancer Res 23:5153–5157PubMed Shpitz B, Gochberg S, Neufeld D, Grankin M, Buklan G, Klein E, Bernheim J (2003) Angiogenic switch in earliest stages of human colonic tumorigenesis. Anticancer Res 23:5153–5157PubMed
41.
Zurück zum Zitat Takahashi Y, Ellis LM, Mai M (2003) The angiogenic switch of human colon cancer occurs simultaneous to initiation of invasion. Oncol Rep 10:9–13PubMed Takahashi Y, Ellis LM, Mai M (2003) The angiogenic switch of human colon cancer occurs simultaneous to initiation of invasion. Oncol Rep 10:9–13PubMed
Metadaten
Titel
Dynamic changes of interleukin-8 network along the colorectal adenoma–carcinoma sequence
verfasst von
Guanglin Cui
Aping Yuan
Rasmus Goll
Barthold Vonen
Jon Florholmen
Publikationsdatum
01.11.2009
Verlag
Springer-Verlag
Erschienen in
Cancer Immunology, Immunotherapy / Ausgabe 11/2009
Print ISSN: 0340-7004
Elektronische ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-009-0702-y

Weitere Artikel der Ausgabe 11/2009

Cancer Immunology, Immunotherapy 11/2009 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.